Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001037389-21-000144
Filing Date
2021-02-11
Accepted
2021-02-10 20:07:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 snca-13g_20201231.txt SC 13G/A 11718
  Complete submission text file 0001037389-21-000144.txt   13402
Mailing Address 800 THIRD AVE NEW YORK NY 10022
Business Address 800 THIRD AVE NEW YORK NY 10022 2124866780
RENAISSANCE TECHNOLOGIES LLC (Filed by) CIK: 0001037389 (see all company filings)

EIN.: 260385758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Subject) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86724 | Film No.: 21615997
SIC: 2836 Biological Products, (No Diagnostic Substances)